Global Exosomes Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 1502

Exosomes are cell-derived vesicles that are present in many and perhaps all eukaryotic fluids, including blood, urine, and cultured medium of cell cultures
Exponential growth in revenue is anticipated over the coming decade due to granular and bottom-up efforts made by researchers in the field. Rising number of research grants and projects by various research organizations will also contribute toward market growth.
In 2018, the global Exosomes market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Exosomes status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Exosomes development in United States, Europe and China.

The key players covered in this study
Fujifilm
Thermo Fisher Scientific
Danaher
Illumina
Qiagen
Takara Bio
Malvern Instruments
Miltenyi Biotec
MBL International
Lonza

Market segment by Type, the product can be split into
Non-coding RNAs
Lipids
mRNA
DNA fragments
Proteins /peptides

Market segment by Application, split into
Cancer
Infectious diseases
Neurodegenerative diseases
Cardiovascular diseases

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Exosomes status, future forecast, growth opportunity, key market and key players.
To present the Exosomes development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Exosomes are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Exosomes Market Size Growth Rate by Type (2014-2025)
1.4.2 Non-coding RNAs
1.4.3 Lipids
1.4.4 mRNA
1.4.5 DNA fragments
1.4.6 Proteins /peptides
1.5 Market by Application
1.5.1 Global Exosomes Market Share by Application (2014-2025)
1.5.2 Cancer
1.5.3 Infectious diseases
1.5.4 Neurodegenerative diseases
1.5.5 Cardiovascular diseases
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Exosomes Market Size
2.2 Exosomes Growth Trends by Regions
2.2.1 Exosomes Market Size by Regions (2014-2025)
2.2.2 Exosomes Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Exosomes Market Size by Manufacturers
3.1.1 Global Exosomes Revenue by Manufacturers (2014-2019)
3.1.2 Global Exosomes Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Exosomes Market Concentration Ratio (CR5 and HHI)
3.2 Exosomes Key Players Head office and Area Served
3.3 Key Players Exosomes Product/Solution/Service
3.4 Date of Enter into Exosomes Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Exosomes Market Size by Type (2014-2019)
4.2 Global Exosomes Market Size by Application (2014-2019)

5 United States
5.1 United States Exosomes Market Size (2014-2019)
5.2 Exosomes Key Players in United States
5.3 United States Exosomes Market Size by Type
5.4 United States Exosomes Market Size by Application

6 Europe
6.1 Europe Exosomes Market Size (2014-2019)
6.2 Exosomes Key Players in Europe
6.3 Europe Exosomes Market Size by Type
6.4 Europe Exosomes Market Size by Application

7 China
7.1 China Exosomes Market Size (2014-2019)
7.2 Exosomes Key Players in China
7.3 China Exosomes Market Size by Type
7.4 China Exosomes Market Size by Application

8 Japan
8.1 Japan Exosomes Market Size (2014-2019)
8.2 Exosomes Key Players in Japan
8.3 Japan Exosomes Market Size by Type
8.4 Japan Exosomes Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Exosomes Market Size (2014-2019)
9.2 Exosomes Key Players in Southeast Asia
9.3 Southeast Asia Exosomes Market Size by Type
9.4 Southeast Asia Exosomes Market Size by Application

10 India
10.1 India Exosomes Market Size (2014-2019)
10.2 Exosomes Key Players in India
10.3 India Exosomes Market Size by Type
10.4 India Exosomes Market Size by Application

11 Central & South America
11.1 Central & South America Exosomes Market Size (2014-2019)
11.2 Exosomes Key Players in Central & South America
11.3 Central & South America Exosomes Market Size by Type
11.4 Central & South America Exosomes Market Size by Application

12 International Players Profiles
12.1 Fujifilm
12.1.1 Fujifilm Company Details
12.1.2 Company Description and Business Overview
12.1.3 Exosomes Introduction
12.1.4 Fujifilm Revenue in Exosomes Business (2014-2019)
12.1.5 Fujifilm Recent Development
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Company Details
12.2.2 Company Description and Business Overview
12.2.3 Exosomes Introduction
12.2.4 Thermo Fisher Scientific Revenue in Exosomes Business (2014-2019)
12.2.5 Thermo Fisher Scientific Recent Development
12.3 Danaher
12.3.1 Danaher Company Details
12.3.2 Company Description and Business Overview
12.3.3 Exosomes Introduction
12.3.4 Danaher Revenue in Exosomes Business (2014-2019)
12.3.5 Danaher Recent Development
12.4 Illumina
12.4.1 Illumina Company Details
12.4.2 Company Description and Business Overview
12.4.3 Exosomes Introduction
12.4.4 Illumina Revenue in Exosomes Business (2014-2019)
12.4.5 Illumina Recent Development
12.5 Qiagen
12.5.1 Qiagen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Exosomes Introduction
12.5.4 Qiagen Revenue in Exosomes Business (2014-2019)
12.5.5 Qiagen Recent Development
12.6 Takara Bio
12.6.1 Takara Bio Company Details
12.6.2 Company Description and Business Overview
12.6.3 Exosomes Introduction
12.6.4 Takara Bio Revenue in Exosomes Business (2014-2019)
12.6.5 Takara Bio Recent Development
12.7 Malvern Instruments
12.7.1 Malvern Instruments Company Details
12.7.2 Company Description and Business Overview
12.7.3 Exosomes Introduction
12.7.4 Malvern Instruments Revenue in Exosomes Business (2014-2019)
12.7.5 Malvern Instruments Recent Development
12.8 Miltenyi Biotec
12.8.1 Miltenyi Biotec Company Details
12.8.2 Company Description and Business Overview
12.8.3 Exosomes Introduction
12.8.4 Miltenyi Biotec Revenue in Exosomes Business (2014-2019)
12.8.5 Miltenyi Biotec Recent Development
12.9 MBL International
12.9.1 MBL International Company Details
12.9.2 Company Description and Business Overview
12.9.3 Exosomes Introduction
12.9.4 MBL International Revenue in Exosomes Business (2014-2019)
12.9.5 MBL International Recent Development
12.10 Lonza
12.10.1 Lonza Company Details
12.10.2 Company Description and Business Overview
12.10.3 Exosomes Introduction
12.10.4 Lonza Revenue in Exosomes Business (2014-2019)
12.10.5 Lonza Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details